Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from BioNano Genomics Inc (BNGO).
Bionano Genomics, Inc. has initiated a registered direct offering, securing an agreement with institutional investors to sell over 6.5 million shares and warrants that could potentially bring in $10 million in gross proceeds. The funds are earmarked for general corporate needs, including R&D, working capital, and debt repayment. Shares and warrants are priced at $1.145 and $1.144 respectively, with the offering set to close around April 8, 2024. This move represents a strategic step by the company to strengthen its financial position and invest in its future growth.
See more data about BNGO stock on TipRanks’ Stock Analysis page.